4//SEC Filing
Dier Mardi 4
Accession 0001628280-25-055164
CIK 0001157601other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:59 PM ET
Size
32.3 KB
Accession
0001628280-25-055164
Insider Transaction Report
Form 4
Dier Mardi
SVP and CFO
Transactions
- Exercise/Conversion
Common Stock
2025-12-02$251.63/sh+4,173$1,050,052→ 14,613 total - Sale
Common Stock
2025-12-02$570.39/sh−320$182,524→ 14,293 total - Sale
Common Stock
2025-12-02$571.99/sh−410$234,516→ 13,883 total - Sale
Common Stock
2025-12-02$573.02/sh−354$202,847→ 13,529 total - Sale
Common Stock
2025-12-02$574.00/sh−717$411,559→ 12,812 total - Sale
Common Stock
2025-12-02$574.95/sh−120$68,994→ 12,692 total - Sale
Common Stock
2025-12-02$576.15/sh−240$138,276→ 12,452 total - Sale
Common Stock
2025-12-02$578.83/sh−258$149,338→ 11,874 total - Sale
Common Stock
2025-12-02$579.85/sh−480$278,329→ 11,394 total - Sale
Common Stock
2025-12-02$589.65/sh−160$94,344→ 10,754 total - Sale
Common Stock
2025-12-02$595.20/sh−74$44,045→ 10,520 total - Sale
Common Stock
2025-12-02$596.18/sh−80$47,695→ 10,440 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-02−4,173→ 9,180 totalExercise: $251.63Exp: 2034-03-01→ Common Stock (4,173 underlying)
Footnotes (17)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $579.59 to $580.46, inclusive.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $585.08 to $585.99, inclusive.
- [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $587.58 to $588.07, inclusive.
- [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $589.13 to $589.96, inclusive.
- [F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $590.15 to $590.58, inclusive.
- [F15]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $595.18 to $595.41, inclusive.
- [F16]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $596.18 to $596.19, inclusive.
- [F17]All shares issued pursuant to the exercise of the options reported herein represent 4,173 shares underlying an overall option award of 13,353 shares. All exercised options had vested. As to the overall option for 13,353 shares, 25% of the shares vested on March 1, 2025, and, thereafter, 6.25% of the shares vested or will vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.17 to $570.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.45 to $572.34, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.48 to $573.38, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.59 to $574.44, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.67 to $575.24, inclusive.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.69 to $576.46, inclusive.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.36 to $578.31, inclusive.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.37 to $579.20, inclusive.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0001574591
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:59 PM ET
- Size
- 32.3 KB